Renal and Cardiovascular Metabolic Impact Caused by Ketogenesis of the SGLT2 Inhibitors.

Autor: Vargas-Delgado AP; AtheroThrombosis Research Unit, Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY 10029, USA.; Instituto Ecuatoriano del Corazón (IECOR), Guayaquil 090513, Ecuador., Arteaga Herrera E; Instituto Ecuatoriano del Corazón (IECOR), Guayaquil 090513, Ecuador., Tumbaco Mite C; Instituto Ecuatoriano del Corazón (IECOR), Guayaquil 090513, Ecuador., Delgado Cedeno P; Instituto Ecuatoriano del Corazón (IECOR), Guayaquil 090513, Ecuador., Van Loon MC; Instituto Ecuatoriano del Corazón (IECOR), Guayaquil 090513, Ecuador., Badimon JJ; AtheroThrombosis Research Unit, Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY 10029, USA.

Publikováno v: International journal of molecular sciences [Int J Mol Sci] 2023 Feb 18; Vol. 24 (4). Date of Electronic Publication: 2023 Feb 18.

Mechanistic Insights of Empagliflozin in Nondiabetic Patients With HFrEF: From the EMPA-TROPISM Study.

Autor: Requena-Ibáñez JA; Atherothrombosis Research Unit, Mount Sinai Heart, Icahn School of Medicine at Mount Sinai School of Medicine, New York, New York, USA; Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Santos-Gallego CG; Atherothrombosis Research Unit, Mount Sinai Heart, Icahn School of Medicine at Mount Sinai School of Medicine, New York, New York, USA; Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Rodriguez-Cordero A; Atherothrombosis Research Unit, Mount Sinai Heart, Icahn School of Medicine at Mount Sinai School of Medicine, New York, New York, USA; Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Vargas-Delgado AP; Atherothrombosis Research Unit, Mount Sinai Heart, Icahn School of Medicine at Mount Sinai School of Medicine, New York, New York, USA; Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Mancini D; Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Sartori S; Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Atallah-Lajam F; Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Giannarelli C; Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Macaluso F; Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Lala A; Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Sanz J; Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Fuster V; Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Badimon JJ; Atherothrombosis Research Unit, Mount Sinai Heart, Icahn School of Medicine at Mount Sinai School of Medicine, New York, New York, USA; Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Electronic address: juan.badimon@mssm.edu.

Publikováno v: JACC. Heart failure [JACC Heart Fail] 2021 Aug; Vol. 9 (8), pp. 578-589.

Randomized Trial of Empagliflozin in Nondiabetic Patients With Heart Failure and Reduced Ejection Fraction.

Autor: Santos-Gallego CG; Cardiology Department, Cardiovascular Institute, Mount Sinai Hospital, New York, New York, USA; AtheroThrombosis Research Unit, Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Vargas-Delgado AP; Cardiology Department, Cardiovascular Institute, Mount Sinai Hospital, New York, New York, USA; AtheroThrombosis Research Unit, Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Requena-Ibanez JA; Cardiology Department, Cardiovascular Institute, Mount Sinai Hospital, New York, New York, USA; AtheroThrombosis Research Unit, Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Garcia-Ropero A; Cardiology Department, Cardiovascular Institute, Mount Sinai Hospital, New York, New York, USA; AtheroThrombosis Research Unit, Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Mancini D; Cardiology Department, Cardiovascular Institute, Mount Sinai Hospital, New York, New York, USA., Pinney S; Cardiology Department, Cardiovascular Institute, Mount Sinai Hospital, New York, New York, USA., Macaluso F; Cardiology Department, Cardiovascular Institute, Mount Sinai Hospital, New York, New York, USA., Sartori S; Cardiology Department, Cardiovascular Institute, Mount Sinai Hospital, New York, New York, USA., Roque M; Cardiology Department, Cardiovascular Institute, Mount Sinai Hospital, New York, New York, USA; AtheroThrombosis Research Unit, Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Sabatel-Perez F; Cardiology Department, Cardiovascular Institute, Mount Sinai Hospital, New York, New York, USA; AtheroThrombosis Research Unit, Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Rodriguez-Cordero A; Cardiology Department, Cardiovascular Institute, Mount Sinai Hospital, New York, New York, USA; AtheroThrombosis Research Unit, Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Zafar MU; Cardiology Department, Cardiovascular Institute, Mount Sinai Hospital, New York, New York, USA; AtheroThrombosis Research Unit, Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Fergus I; Cardiology Department, Cardiovascular Institute, Mount Sinai Hospital, New York, New York, USA., Atallah-Lajam F; Cardiology Department, Cardiovascular Institute, Mount Sinai Hospital, New York, New York, USA., Contreras JP; Cardiology Department, Cardiovascular Institute, Mount Sinai Hospital, New York, New York, USA., Varley C; Cardiology Department, Cardiovascular Institute, Mount Sinai Hospital, New York, New York, USA., Moreno PR; Cardiology Department, Cardiovascular Institute, Mount Sinai Hospital, New York, New York, USA., Abascal VM; Cardiology Department, Cardiovascular Institute, Mount Sinai Hospital, New York, New York, USA., Lala A; Cardiology Department, Cardiovascular Institute, Mount Sinai Hospital, New York, New York, USA., Tamler R; Division of Endocrinology, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Sanz J; Cardiology Department, Cardiovascular Institute, Mount Sinai Hospital, New York, New York, USA., Fuster V; Cardiology Department, Cardiovascular Institute, Mount Sinai Hospital, New York, New York, USA; Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain., Badimon JJ; Cardiology Department, Cardiovascular Institute, Mount Sinai Hospital, New York, New York, USA; AtheroThrombosis Research Unit, Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Electronic address: juan.badimon@mssm.edu.

Publikováno v: Journal of the American College of Cardiology [J Am Coll Cardiol] 2021 Jan 26; Vol. 77 (3), pp. 243-255. Date of Electronic Publication: 2020 Nov 13.

Correlation between myocardial strain and adverse remodeling in a non-diabetic model of heart failure following empagliflozin therapy.

Autor: Garcia-Ropero A; Barts Heart Centre, St. Bartholomew's Hospital, Barts Health NHS Trust , London, UK., Santos-Gallego CG; Atherothrombosis Research Unit, Mount Sinai Heart, Icahn School of Medicine at Mount Sinai , New York, NY, USA., Vargas-Delgado AP; Atherothrombosis Research Unit, Mount Sinai Heart, Icahn School of Medicine at Mount Sinai , New York, NY, USA., Requena-Ibanez JA; Atherothrombosis Research Unit, Mount Sinai Heart, Icahn School of Medicine at Mount Sinai , New York, NY, USA., Picatoste B; Biochemistry Department, Weill Cornell Medical College , New York, NY, USA., Ishikawa K; Atherothrombosis Research Unit, Mount Sinai Heart, Icahn School of Medicine at Mount Sinai , New York, NY, USA., Sanz J; Cardiovascular Institute, Icahn School of Medicine at Mount Sinai , New York, NY, USA., Tunon J; Department of Cardiology, IIS-Hospital Universitario Fundación Jiménez Díaz - Quironsalud , Madrid, Spain., Badimon JJ; Atherothrombosis Research Unit, Mount Sinai Heart, Icahn School of Medicine at Mount Sinai , New York, NY, USA.

Publikováno v: Expert review of cardiovascular therapy [Expert Rev Cardiovasc Ther] 2020 Sep; Vol. 18 (9), pp. 635-642. Date of Electronic Publication: 2020 Aug 09.

Inhibition of Sodium Glucose Cotransporters Improves Cardiac Performance.

Autor: García-Ropero Á; Atherothrombosis Research Unit, Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.; Cardiology Department, Imperial College London, The Royal Brompton and Harefield Hospital, London 6W3 6NP, UK., Vargas-Delgado AP; Atherothrombosis Research Unit, Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.; Instituto Ecuatoriano del Corazón IECOR, Guayaquil 090513, Ecuador., Santos-Gallego CG; Atherothrombosis Research Unit, Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Badimon JJ; Atherothrombosis Research Unit, Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. juan.badimon@mssm.edu.

Publikováno v: International journal of molecular sciences [Int J Mol Sci] 2019 Jul 04; Vol. 20 (13). Date of Electronic Publication: 2019 Jul 04.